Skip to search formSkip to main contentSkip to account menu

Prior Immunotherapy

Originally, therapeutic administration of serum or gamma globulin containing preformed antibodies produced by another individual; currently… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
There is limited real‐world data on the efficacy and safety of combination programmed cell death protein‐1 (PD‐1) inhibitor… 
2019
2019
Abstract Background N is an oral triple angiokinase inhibitor approved in 61 countries for use with D to treat locally advanced… 
2019
2019
Introduction: Treatment with rhIL-15 has been reported to significantly increase levels of circulating CD8+ T cells, NK cells… 
2017
2017
TPS4154Background: Optimal treatment strategy beyond systemic chemotherapy for LAPC remains undefined. SBRT improves local… 
2005
2005
7559 Background: PI-88 is a novel anti-angiogenic drug, which acts by inhibiting heparanase and binding to pro-angiogenic growth… 
2004
2004
7554 Background: To determine the efficacy and safety of the novel camptothecin, karenitecin (BNP1350), in patients with… 
Highly Cited
2000
Highly Cited
2000
The aim of this study was to examine the tolerability, antitumor activity, and biological effects of a new schedule of i.v… 
1994
1994
Summary: patients (n=22) with metastatic or unresectable colorectal carcinoma were treated with interleukin (IL)-2 and lymphokine…